Literature DB >> 16740213

Elevated day 3 FSH/LH ratio due to low LH concentrations predicts reduced ovarian response.

A Shrim1, S E Elizur, D S Seidman, J Rabinovici, A Wiser, J Dor.   

Abstract

Adequate ovarian response, essential for successful IVF, cannot be accurately predicted. This study retrospectively reviewed all patients undergoing IVF from 1998 to 2001. Inclusion criteria were age <41 years at treatment onset and a basal day 3 serum FSH concentration <12 IU/l. Women with FSH <or=8 IU/l underwent a secondary analysis. Two groups emerged according to basal day 3 serum FSH/LH ratio: >or=3 in group 1 and <3 in group 2 (controls). Age at treatment initiation, basal serum day 3 FSH and LH concentrations, peak serum oestradiol concentration, number of retrieved and fertilized oocytes and pregnancy rate were analysed. Groups 1 (n = 41, 111 IVF treatment cycles) and 2 (n = 596, 1,434 IVF treatment cycles) were similar in term of woman's mean age. Group 1 had significantly higher mean basal day 3 FSH concentration (P < 0.01) and significantly lower oestradiol concentrations at oocyte retrieval (P < 0.01), mean number of oocytes retrieved and fertilized (P < 0.01) and pregnancy rate (P = 0.016). The same trend persisted after excluding 98 patients with basal FSH concentrations >8 IU/l. In conclusion, elevated day 3 FSH/LH ratio is associated with an inferior outcome in IVF treatment cycles and may be used as an additional predictor for decreased ovarian response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740213     DOI: 10.1016/s1472-6483(10)61993-1

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  9 in total

1.  Persistent organic pollutants as predictors of increased FSH:LH ratio in naturally cycling, reproductive age women.

Authors:  Mia V Gallo; Julia Ravenscroft; David O Carpenter; Lawrence M Schell
Journal:  Environ Res       Date:  2018-04-02       Impact factor: 6.498

2.  Do young women with unexplained infertility show manifestations of decreased ovarian reserve?

Authors:  Noa Abrahami; Ido Izhaki; Johnny S Younis
Journal:  J Assist Reprod Genet       Date:  2019-05-21       Impact factor: 3.412

3.  Elevated day 3 FSH/LH ratio: a marker to predict IVF outcome in young and older women.

Authors:  Berna Seckin; Figen Turkcapar; Gulnur Ozaksit
Journal:  J Assist Reprod Genet       Date:  2011-12-20       Impact factor: 3.412

4.  An in silico model using prognostic genetic factors for ovarian response in controlled ovarian stimulation: A systematic review.

Authors:  B S Eisele; G C Villalba Silva; C Bessow; R Donato; V K Genro; J S Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2021-03-31       Impact factor: 3.357

5.  Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol.

Authors:  Frank J Broekmans; Pierre J M Verweij; Marinus J C Eijkemans; Bernadette M J L Mannaerts; Han Witjes
Journal:  Hum Reprod       Date:  2014-06-05       Impact factor: 6.918

6.  Elevated levels of FMR1 mRNA in granulosa cells are associated with low ovarian reserve in FMR1 premutation carriers.

Authors:  Shai E Elizur; Oshrit Lebovitz; Sanaz Derech-Haim; Olga Dratviman-Storobinsky; Baruch Feldman; Jehoshua Dor; Raoul Orvieto; Yoram Cohen
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

Review 7.  Endometriosis and polycystic ovary syndrome are diametric disorders.

Authors:  Natalie L Dinsdale; Bernard J Crespi
Journal:  Evol Appl       Date:  2021-05-14       Impact factor: 4.929

8.  Correlation of the Day 3 FSH/LH Ratio and LH Concentration in Predicting IVF Outcome.

Authors:  Sudha Prasad; Teena Gupta; Aabha Divya
Journal:  J Reprod Infertil       Date:  2013-01

9.  What is the effect of the early follicular phase FSH/LH ratio on the number of mature oocytes and embryo development?

Authors:  Özgür Arat; Derya Deveci; Zehra Sema Özkan; Sevim Tuncer Can
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.